nonsteroidal antiinflammatory drugs nsaids are widely usedit is well recognised that they may adversely cause damage throughout the gastrointestinal tract and aggravate preexisting diseasetheir side effects on the upper gastrointestinal tract can be assessed by various means each study type has different clinical connotationsshortterm use less than 14 days demonstrates dosedependent damage of prescribed nsaids the damage is proportional to the acidity of the drugs and not seen with cyclooxygenase2 cox2 selective inhibitors that have a pka over 70there have not been any serious outcomes such as bleeding or perforation in these studies and helicobacter pylori hp plays no role in this damagelongterm 3 months or more endoscopy studies in patients show ulcer rates from 1535 with the various nsaids but serious outcomes are exceedingly rareepidemiological studies show an association between nsaid intake and serious eventsibuprofen is consistently at the lower end of toxicity rankings whereas ketorolac and azapropazone are the worstthe risk of bleeding is increased with advancing age presence of hp previous history of bleeding anticoagulant use etcthe megatrials show that cox2 selective agents halve the bleeding episodes but nsaidinduced gastric bleeding is very rare usually less than 1 in 200 subjects taking them for a yearseventy percent of patients develop nsaidenteropathy which is associated with intestinal blood and protein loss and rarely stricturesoverthecounter otc use of ibuprofen and diclofenac is associated with symptomatic gastrointestinal side effects comparable with placeboibuprofen is shown to be remarkably well tolerated at otc doses in a number of studiesthere are recent studies to suggest that otc nsaids should be taken on a fasting stomach not with food as commonly advocated 2012 blackwell publishing ltd